| Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics R Oerlemans, AJ Ruiz-Moreno, Y Cong, ND Kumar, ... RSC medicinal chemistry 12 (3), 370-379, 2021 | 63 | 2021 |
| Characterization of gut microbial structural variations as determinants of human bile acid metabolism D Wang, M Doestzada, L Chen, S Andreu-Sanchez, ... Cell Host & Microbe 29 (12), 1802-1814. e5, 2021 | 53 | 2021 |
| Synthetic peptides that antagonize the angiotensin-converting enzyme-2 (ACE-2) interaction with SARS-CoV-2 receptor binding spike protein A Sadremomtaz, ZM Al-Dahmani, AJ Ruiz-Moreno, A Monti, C Wang, ... Journal of Medicinal Chemistry 65 (4), 2836-2847, 2021 | 33 | 2021 |
| Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells C Aguirre-Alvarado, A Segura-Cabrera, I Velázquez-Quesada, ... Oncotarget 7 (17), 23772, 2016 | 24 | 2016 |
| Benchmark of generic shapes for macrocycles A Reyes Romero, AJ Ruiz-Moreno, MR Groves, M Velasco-Velázquez, ... Journal of chemical information and modeling 60 (12), 6298-6313, 2020 | 12 | 2020 |
| Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire S Andreu-Sánchez, AR Bourgonje, T Vogl, A Kurilshikov, S Leviatan, ... Immunity 56 (6), 1376-1392. e8, 2023 | 8 | 2023 |
| Host genetic regulation of human gut microbial structural variation DV Zhernakova, D Wang, L Liu, S Andreu-Sánchez, Y Zhang, ... Nature, 1-9, 2024 | 7 | 2024 |
| In silico design and selection of new tetrahydroisoquinoline-based CD44 antagonist candidates AJ Ruiz-Moreno, A Reyes-Romero, A Dömling, MA Velasco-Velázquez Molecules 26 (7), 1877, 2021 | 7 | 2021 |
| Scaffolding-induced property modulation of chemical space J Li, V Di Lorenzo, P Patil, AJ Ruiz-Moreno, K Kurpiewska, ... ACS Combinatorial Science 22 (7), 356-360, 2020 | 6 | 2020 |
| Pranlukast antagonizes cd49f and reduces stemness in triple-negative breast cancer cells I Velázquez-Quesada, AJ Ruiz-Moreno, D Casique-Aguirre, ... Drug Design, Development and Therapy, 1799-1811, 2020 | 6 | 2020 |
| Gliptin repurposing for COVID-19 M Groves, A Domling, AJR Moreno, AR Romero, C Neochoritis, ... | 6 | 2020 |
| Reverse docking for the identification of molecular targets of anticancer compounds AJ Ruiz-Moreno, A Dömling, MA Velasco-Velázquez Cancer Cell Signaling: Methods and Protocols, 31-43, 2021 | 4 | 2021 |
| Repositioning of etravirine as a potential CK1ε inhibitor by virtual screening L Córdova-Bahena, AA Sánchez-Álvarez, AJ Ruiz-Moreno, ... Pharmaceuticals 15 (1), 8, 2021 | 3 | 2021 |
| Guide for Selection of Relevant Cell Lines During the Evaluation of new Anti-Cancer Compounds AJ Ruiz-Moreno, P Torres-Barrera, M Velázquez-Paniagua, A Dömling, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018 | 2 | 2018 |
| ViSAS for Entering Chemical Space: Virtual Screening of Analog Series and Related Advances JJ Naveja-Romero, FI Saldívar-González, DL Prado-Romero, ... | 1 | 2022 |
| Implementation of computational methodologies for drug discovery AJ Ruiz-Moreno, MA Velasco-Velázquez, A Dömling Silico Design and Selection of CD44 Antagonists 1, 2021 | 1 | 2021 |
| Small‐Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells C Wang, B Zhang, Y Cong, X Du, S Chen, L Visser, A Ruiz-Moreno, ... ChemMedChem, e202300688, 2024 | | 2024 |
| Visualization, Exploration, and Screening of Chemical Space in Drug Discovery JJ Naveja, FI Saldívar‐González, DL Prado‐Romero, AJ Ruiz‐Moreno, ... Computational Drug Discovery: Methods and Applications 2, 365-393, 2024 | | 2024 |
| Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 Mpro Inhibitors from Large Chemical Libraries AJ Ruiz-Moreno, R Cedillo-González, L Cordova-Bahena, Z An, ... Journal of Chemical Information and Modeling 64 (6), 1984-1995, 2024 | | 2024 |
| Abstract 1553 Identification of a SARS-CoV-2 Mpro inhibitor from large chemical libraries using a consensus pharmacophore M Velasco-Velazquez, A Ruiz-Moreno, R Cedillo-González, ... Journal of Biological Chemistry 300 (3), 2024 | | 2024 |
Marco Velasco-VelázquezProfesorVerified email at unam.mx
